Pluripotent stem cells are entering early phase 1 and 2 clinical trials for a range of applications, including the treatment of macular degeneration and other eye diseases, spinal cord injury, heart disease, type 1 diabetes, and Parkinson's disease. By necessity, both pluripotent embryonic stem…
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2woq4JG
http://ift.tt/2fbyBMG
Ιατρική : Τα αισθητικά συστήματα της όρασης,ακοής,αφής,γεύσης και όσφρησης.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Subcutaneous zygomycosis presenting as soft-tissue ‘tumour’ over scapula – case report and review of literature : 2016-10-06T18-09-02Z Sou...
-
Abstract Objectives We examined the effect of biologic disease-modifying anti-rheumatic drugs on the time to pregnancy in patients with ...
-
Publication date: Available online 2 August 2017 Source: Neuroscience Research Author(s): Mamoru Takeda, Masanori Nasu, Takuya Kanazawa, ...
-
Abstract Objectives Innovative mental health care delivery models have been proposed as a method to address disparities in access and uti...
-
Immune response profile of primary tumour, sentinel and non-sentinel axillary lymph nodes related to metastasis in breast cancer: an immunoh...
-
Abstract Objectives We present an overview of the literature on caregiver stress in children with craniosynostosis and report common tre...
-
Abstract Background In order to gain insight into the early effects drawn by JAK inhibitors on intra-joint JAK/STAT-dependent signaling,...
-
Abstract Introduction We report a pure distraction injury of the upper thoracic spine and uncontrolled hyperthermia without an infectious...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου